Skip to main content

Failure as a sign of strength

Artemis CIO Paras Anand says that any genuinely robust financial system should be in some way Darwinian, as the survival of the fittest is an essential component of market sustainability. This is why the failure of many ‘zombie’ companies in this environment is nothing for investors to fear.

Nassim Nicholas Taleb first popularised the concept of “black swans” in a book published in early 2007. Only months later the world witnessed just such a phenomenon: the global financial crisis.

One of Taleb’s key arguments went relatively unnoticed amid the turmoil. A broken system should be allowed to fail, he said, as this helps protect against the black swans still to come – whereas simply propping up a defective construct only renders it even more exposed.

The shift from quantitative easing (QE) to tightening and the rapid rise in interest rates as central bankers battle to contain inflation have brought volatility to capital markets. Though the S&P 500 is up 21% from its low last October, this rally has been led by a very small number of stocks, suggesting market fragility.

We have seen war in Europe and Putin’s regime under threat, a cost-of-living crisis, the fall of the third-largest bank ever to fold in the US and the bailing out of a long-time European financial powerhouse. It would be ridiculous to suggest these are trifling occurrences, but if a golden age of easy money has given way to a search for silver linings then there are plenty to be found. Inflation has lifted wages for the first time in years and enabled companies to recalibrate prices. Even business failures can offer encouragement.

QE and Covid

As Taleb suggested, an inherent feature of any genuinely robust system should be that it is in some way Darwinian. Economically, the survival of the fittest is an essential component of its sustainability.

QE did not entirely disrupt this process, but it was designed to make life easier for companies by making debt cheaper. Many companies that should have folded in the past decade stayed afloat. Others overexpanded.

Just as central bankers were beginning the job of reversing QE, Covid arrived. Government-backed furlough schemes temporarily removed the Darwinian element altogether, effectively ensuring that nothing should be allowed to fail.

This led to a market environment in which good management was often not fully rewarded and bad management was frequently unpunished. Many companies willingly entered a self-induced coma, secure in the knowledge that life support was at hand and issues such as customer acquisition and market share need not concern them unduly.

In time, of course, these businesses awoke to discover the world had changed dramatically. Such “zombie companies” now account for a sizeable proportion of the firms struggling to survive or closing.

Meanwhile, many businesses that were already resilient and which continued to adapt and innovate have emerged even stronger. In tandem, the investors who backed them can now increasingly expect to benefit accordingly.

The natural order

In turmoil lies opportunity. The trauma in March in the banking arena provides a neat illustration. Consider the respective fates of Credit Suisse and its saviour, UBS, and how they eventually intersected.

Credit Suisse had been embroiled in a variety of scandals in recent years. The Archegos default, the Greensill Capital collapse, the Mozambique tuna bond fraud, the Bulgarian cocaine traffickers’ money laundering scandal – these incidents sound like ever more bizarre chapter headings in a pulp-fiction novel. They damaged the bank’s reputation, and the losses and fines ran to billions. Credit Suisse underwent a series of shake-ups at executive level and suffered substantial losses.

By contrast, UBS made a string of shrewd moves while maintaining a focus on prudent risk management. Its investment banking division posted especially impressive numbers during the pandemic. The $3.2 billion purchase of Credit Suisse – which the Wall Street Journal touted as “the deal of the decade” – was the culmination of many years of sound decisions.

So a poorly managed company put itself in a position to fail. A well-managed company put itself in a position to grow. And, thanks to the broader robustness of the system, the world kept turning.

Signs of life

Today feels like the end of the 1990s and early 2000s. Markets were volatile; the NASDAQ fell dramatically; Enron and WorldCom went bust; but the economy, in aggregate, was reasonably healthy.

Critics will say, with some justification, that QE endured for too long. Covid extended it. Coming off the drug of cheap capital will not be easy. Its withdrawal has led to isolated failures – and will lead to more. But each failure need not be a portent of all-pervading catastrophe. What we are witnessing is the unwinding of excesses and the natural cycle of disruptive innovation. These are signs of a healthy economy.

Investors sometimes need to step away from the screens and ask if markets are fully reflecting what is happening outside. I would argue not – the real economy feels more robust in aggregate. For the selective investor who backs good companies and good management, herein may lie opportunity.

Investment in a fund concerns the acquisition of units/shares in the fund and not in the underlying assets of the fund.

Reference to specific shares or companies should not be taken as advice or a recommendation to invest in them.

For information on sustainability-related aspects of a fund, visit the relevant fund page on this website.

For information about Artemis’ fund structures and registration status, visit artemisfunds.com/fund-structures

Any research and analysis in this communication has been obtained by Artemis for its own use. Although this communication is based on sources of information that Artemis believes to be reliable, no guarantee is given as to its accuracy or completeness.

Any statements are based on Artemis’ current opinions and are subject to change without notice. They are not intended to provide investment advice and should not be construed as a recommendation.

Third parties (including FTSE and Morningstar) whose data may be included in this document do not accept any liability for errors or omissions. For information, visit artemisfunds.com/third-party-data.

Important information
The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.